CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-07 | Welch David F Director | Purchase | +5,000 | $0.99 | $5K | 15,000 |
| 2017-02-06 | Welch David F Director | Purchase | +5,000 | $0.96 | $5K | 10,000 |
| 2017-02-03 | Welch David F Director | Purchase | +5,000 | $0.95 | $5K | 5,000 |
| 2017-01-20 | Welch David F Director | Purchase | +9,983 | $1.07 | $11K | 1,791,415 |
| 2017-01-19 | Welch David F Director | Purchase | +10,000 | $0.95 | $10K | 1,781,432 |
| 2017-01-18 | Welch David F Director | Purchase | +5,000 | $1.00 | $5K | 1,771,432 |
| 2017-01-12 | Welch David F Director | Purchase | +5,000 | $0.95 | $5K | 15,000 |
| 2017-01-11 | Welch David F Director | Purchase | +5,000 | $0.94 | $5K | 10,000 |
| 2017-01-10 | Welch David F Director | Purchase | +5,000 | $0.91 | $5K | 5,000 |
| 2016-10-31 | Huh Hoyoung Chairman, Scientific Adv. Bd. | Grant or award · Stock Option (right to buy) | +4,000,000 | 4,000,000 | ||
| 2016-10-31 | Welch David F Director | Grant or award · Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2016-10-31 | Sherman Barry Michael Director | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-10-31 | Fields Morgan Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2016-10-31 | Elam Nevan C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +3,500,000 | 3,500,000 | ||
| 2016-03-31 | Huh Hoyoung Director | Other acquisition · Warrant to purchase common stock | +234,700 | 234,700 | ||
| 2015-12-10 | Elam Nevan C Chief Executive Officer | Purchase · Series A Convertible Preferred Stock | +76,923 | $1.95 | $150K | 76,923 |
| 2015-12-10 | Welch David F Director | Purchase · Series A Convertible Preferred Stock | +256,410 | $1.95 | $500K | 256,410 |
| 2015-02-09 | Elam Nevan C Chief Executive Officer | Sale | −842,949 | 0 | ||
| 2015-02-09 | Elam Nevan C Chief Executive Officer | Sale · Warrant to Purchase Common Stock | −39,117 | 0 | ||
| 2014-04-30 | Howe Steve Director | Grant or award · Stock Option (right to buy) | +125,000 | 1,125,000 |
Page 13 of 14 · 279 trades